How long does it take to take Bosentan to reduce pulmonary hypertension?
Bosentan is a drug used to treat pulmonary arterial hypertension. It exerts its therapeutic effect by antagonizing endothelinA receptors and endothelin B receptors. It can expand pulmonary arteries, reduce vascular resistance, and effectively reduce pulmonary arterial hypertension. Regarding how long it takes to reduce pulmonary hypertension after taking Bosentan, the specific situation needs to be judged based on your own condition and physical constitution.
When the condition is not serious, taking bosentan for about a month can effectively reduce the pulmonary artery pressure and gradually restore the pulmonary artery pressure. If the condition is more serious or the patient is not sensitive to the drug, it may take two months of continuous use to see obvious effects.
It is worth noting that the taking time and effects of bosentan vary among individuals, so patients need to adjust their medication according to their doctor's advice and guidance. At the same time, if the drug is not effective, you should seek medical treatment in time so that the doctor can adjust the treatment plan according to the specific situation.
Bosentan tablets are currently on the market in China and have been included in domestic medical insurance reimbursement items. The specifications of Bosentan on the domestic market are 125mg*56 tablets, and the price after medical insurance is about 3,000 yuan. It is understood that there are related generic versions of bosentan on the market overseas. The generic version of bosentan listed overseas is produced by India's cipla pharmaceuticals. The price of 125ng*20 tablets is about 400 yuan. Patient feedback on the generic version of Bosentan launched overseas is also good. Patients can choose the product that suits them according to their own conditions. If the patient has more questions about bosentan, please consult Yaofenxiang’s medical consultant for more information.
In general, the taking time of bosentan varies depending on the individual's condition and constitution. Patients need to be patient and follow the doctor's instructions for treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)